DexCom (DXCM) Misses Q2 EPS by 2c
Tweet
Share
E-mailGet Alerts DXCM Hot Sheet
Price: $68.86 --0%
EPS Growth %: +27.1%
Financial Fact:
Interest expense: -200K
Today's EPS Names:
PKE, LNN, More
EPS Growth %: +27.1%
Financial Fact:
Interest expense: -200K
Today's EPS Names:
PKE, LNN, More
Join SI Premium – FREE
DexCom (NASDAQ: DXCM) reported Q2 EPS of ($0.05), $0.02 worse than the analyst estimate of ($0.03). Revenue for the quarter came in at $93.2 million versus the consensus estimate of $84.81 million.
For earnings history and earnings-related data on DexCom (DXCM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Greenbrier Cos. (GBX) Reports In-Line Q3 EPS
- Biogen expects $164M R&D charge to hit Q2 2026 earnings
- Culp, Inc. (CULP) Misses Q4 EPS by 12c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
